{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:07Z","timestamp":1793196547115,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.clindermatol.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T06:29:10Z","timestamp":1523514550000},"page":"450-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Dermatomyositis: Current concepts"],"prefix":"10.1016","volume":"36","author":[{"given":"Ivan","family":"Bogdanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kazandjieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvigor","family":"Darlenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Tsankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2018.04.003_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12016-017-8652-1","article-title":"Cutaneous manifestations of dermatomyositis: A comprehensive review","volume":"53","author":"Mainetti","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0010","doi-asserted-by":"crossref","unstructured":"Thompson C, Piguet V, Choy E. The pathogenesis of dermatomyositis. Br J Dermatol doi:https:\/\/doi.org\/10.1111\/bjd.15607 [published online ahead of print May 24, 2017].","DOI":"10.1111\/bjd.15607"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0015","series-title":"Dermatomyositis: Advances in Recognition, Understanding and Management","author":"Dourmishev","year":"2009"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0020","first-page":"273","article-title":"Dermatomyositis\u2014part 1: Definition, epidemiology, etiology and pathogenesis, and clinics","volume":"14","author":"Ramos","year":"2016","journal-title":"Skinmed"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","article-title":"Incidence of dermatomyositis and clinically amyopathic dermatomyositis: A population-based study in Olmsted County, Minnesota","volume":"146","author":"Bendewald","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0030","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI117520","article-title":"High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments","volume":"94","author":"Basta","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0035","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.1780390910","article-title":"Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0040","series-title":"Skin Manifestations in Rheumatic Disease","first-page":"231","article-title":"Skin manifestation in dermatomyositis","author":"Czirj\u00e1k","year":"2014"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0045","first-page":"505","article-title":"Cutaneous signs of classical dermatomyositis","volume":"149","author":"Auriemma","year":"2014","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0019-5154.100486","article-title":"Clinical presentation and evaluation of dermatomyositis","volume":"57","author":"Marvi","year":"2012","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0055","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/archderm.1974.01630120016003","article-title":"Cuticular changes in dermatomyositis. A clinical sign","volume":"110","author":"Samitz","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0060","doi-asserted-by":"crossref","unstructured":"Park SJ, Choi IH, Kim HS. Rapid changes in capillary morphology and architecture in a patient with dermatomyositis. Korean J Intern Med doi:https:\/\/doi.org\/10.3904\/kjim.2017.338 [published online ahead of print Jan. 5, 2018].","DOI":"10.3904\/kjim.2017.338"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1346-8138.2010.01092.x","article-title":"Dermoscopy findings of nail fold capillaries in connective tissue diseases","volume":"38","author":"Hasegawa","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8635(02)00021-9","article-title":"Dermatomyositis: An overview of recent progress with emphasis on dermatologic aspects","volume":"20","author":"Sontheimer","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0075","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/annrheumdis-2016-eular.5174","article-title":"AB0629 design of a randomized, double-blind, placebo-controlled phase 2 clinical trial of the toll-like receptor antagonist IMO-8400 in patients with dermatomyositis","volume":"75","author":"Gordon","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0080","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1503\/cmaj.061205","article-title":"Periorbital and facial swelling due to dermatomyositis","volume":"176","author":"Rafailidis","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0085","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/00002281-200311000-00006","article-title":"Skin involvement in dermatomyositis","volume":"15","author":"Santmyire-Rosenberger","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0090","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1365-4362.2003.01696.x","article-title":"Periorbital edema as the presenting sign of dermatomyositis","volume":"42","author":"Hall","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0095","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(98)70263-4","article-title":"Dermatomyositis","volume":"39","author":"Kovacs","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0100","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/acr.22498","article-title":"Cutaneous ulceration in dermatomyositis: Association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease","volume":"67","author":"Narang","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0105","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acr.21728","article-title":"Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody","volume":"64","author":"Cao","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-91-4-577","article-title":"A cutaneous lesion associated with myositis","volume":"91","author":"Stahl","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1756-0500-7-303","article-title":"Mechanic\u2019s hands revisited: Is this sign still useful for diagnosis in patients with lung involvement of collagen vascular diseases?","volume":"7","author":"Sohara","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0120","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1067\/mjd.2000.102648","article-title":"An unusual presentation of dermatomyositis: The type Wong variant revisited","volume":"43","author":"Lupton","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0125","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2133.1969.tb16031.x","article-title":"Dermatomyositis: A clinical investigation of twenty-three cases in Hong Kong","volume":"81","author":"Wong","year":"1969","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0130","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archderm.135.11.1370","article-title":"Gingival telangiectases: An underappreciated physical sign of juvenile dermatomyositis","volume":"135","author":"Ghali","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamadermatol.2016.1429","article-title":"Ovoid palatal patch in dermatomyositis: A novel finding associated with anti-TIF1-\u03b3 (p155) antibodies","volume":"152","author":"Bernet","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1525-1470.2011.01585.x","article-title":"Inverse Gottron\u2019s papules: An unusual cutaneous manifestation of juvenile dermatomyositis","volume":"29","author":"Quinter","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/RHU.0000000000000377","article-title":"Digital pulp ulcerations and inverse Gottron papules in melanoma differentiation-associated gene 5-related dermatomyositis","volume":"22","author":"Ward","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2332\/allergolint.10-CR-0213","article-title":"A case of juvenile dermatomyositis manifesting inflammatory epidermal nevus-like skin lesions: Unrecognized cutaneous manifestation of blaschkitis?","volume":"59","author":"Takahashi","year":"2010","journal-title":"Allergol Int"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0155","article-title":"The \u201csleeve sign\u201d in dermatomyositis [abstract]","volume":"67","author":"Lahoutiharahdashti","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0160","article-title":"Clinical characterization of itch in dermatomyositis and the role of increased skin interleukin-31 [abstract]","volume":"68","author":"Kim","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.det.2016.02.006","article-title":"Practice and educational gaps in lupus, dermatomyositis, and morphea","volume":"34","author":"Fett","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0170","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.4158\/EP13145.CR","article-title":"Three cases of dermatomyositis associated with papillary thyroid cancer","volume":"19","author":"Shah","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3899\/jrheum.140566","article-title":"Polymyositis\/dermatomyositis and malignancy risk: A metaanalysis study","volume":"42","author":"Yang","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: A case-control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","article-title":"Juvenile dermatomyositis as a paraneoplastic phenomenon: An update","volume":"32","author":"Morris","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003643.pub4","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","author":"Gordon","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0200","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/17512433.2017.1353910","article-title":"Pharmacological management of dermatomyositis","volume":"10","author":"Griger","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-4615-4857-7_54","article-title":"The effect of methylprednisolone pulse therapy in polymyositis\/dermatomyositis","volume":"455","author":"Bolosiu","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nmd.2010.03.011","article-title":"Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial","volume":"20","author":"van de Vlekkert","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0215","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/BOR.0000000000000430","article-title":"Recent clinical trials in idiopathic inflammatory myopathies","volume":"29","author":"Leclair","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","article-title":"Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis","volume":"29","author":"Vencovsky","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","article-title":"Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens","volume":"41","author":"Villalba","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0230","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/1756-185X.12931","article-title":"Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis","volume":"19","author":"Ueno","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0235","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2230.2011.04188.x","article-title":"Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions","volume":"37","author":"Hornung","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0240","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.138.9.1231","article-title":"Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus","volume":"138","author":"Pelle","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0245","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2009.04.003","article-title":"Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis","volume":"9","author":"Danieli","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0255","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2013.06.007","article-title":"Intravenous immunoglobulin for refractory cutaneous dermatomyositis: A retrospective analysis from an academic medical center","volume":"69","author":"Femia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0260","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","article-title":"Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application","volume":"10","author":"Danieli","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0265","first-page":"1009","article-title":"Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature","volume":"27","author":"Rios Fernandez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0270","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: An open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0275","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0280","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","article-title":"A pilot trial of rituximab in the treatment of patients with dermatomyositis","volume":"143","author":"Chung","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0285","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/rheumatology\/kew396","article-title":"Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab","volume":"56","author":"Aggarwal","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0290","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10067-014-2507-4","article-title":"Abatacept as a successful therapy for myositis\u2014a case-based review","volume":"34","author":"Kerola","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0295","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/acr.22198","article-title":"Pilot study of etanercept in patients with refractory juvenile dermatomyositis","volume":"66","author":"Rouster-Stevens","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0300","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1309\/AJCPPJUQ9DNR1GHP","article-title":"Donor cell-derived leukemias\/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: A clinicopathologic study of 10 cases and a comprehensive review of the literature","volume":"135","author":"Wang","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0305","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00128071-200607060-00002","article-title":"Management of cutaneous dermatomyositis: Current therapeutic options","volume":"7","author":"Quain","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09546630310018509","article-title":"Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: A pilot study","volume":"15","author":"Hollar","year":"2004","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0315","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5021\/ad.2011.23.3.348","article-title":"Successful treatment of cutaneous lesions of dermatomyositis with topical pimecrolimus","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0320","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/art.21332","article-title":"Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis","volume":"53","author":"Maillard","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0325","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3899\/jrheum.131145","article-title":"Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis\u2014a randomized controlled single-blinded study with a 2-year followup","volume":"41","author":"Alexanderson","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0330","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/rheumatology\/ker292","article-title":"Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy\u2014a systematic review","volume":"50","author":"Habers","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CDLI.2.1.1-9.1995","article-title":"Laboratory evaluation of the inflammatory myopathies","volume":"2","author":"Rider","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0340","first-page":"41","article-title":"Use of dermoscopy in the evaluation of connective tissue diseases","volume":"1","author":"Hasegawa","year":"2015","journal-title":"Dermatol Clin Res"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0345","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00105-015-3659-0","article-title":"Dermatomyositis-update","volume":"66","author":"Volc-Platzer","year":"2015","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0350","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13317-014-0060-4","article-title":"Myositis autoantibodies and clinical phenotypes","volume":"5","author":"Ghirardello","year":"2014","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.clindermatol.2018.04.003_bb0355","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod Rheumatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X18300622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X18300622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T15:35:31Z","timestamp":1604158531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X18300622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0738081X18300622"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.003","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatomyositis: Current concepts","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}